Home/Filings/4/0001104659-21-025572
4//SEC Filing

Lamstein Joshua R 4

Accession 0001104659-21-025572

CIK 0001772028other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 10:12 AM ET

Size

5.2 KB

Accession

0001104659-21-025572

Insider Transaction Report

Form 4
Period: 2021-02-19
Lamstein Joshua R
DirectorChairman
Transactions
  • Purchase

    Common Stock, par value $0.001

    2021-02-19$10.93/sh+500$5,465116,697 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.89 to $10.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Issuer

Scopus BioPharma Inc.

CIK 0001772028

Entity typeother

Related Parties

1
  • filerCIK 0001665280

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 10:12 AM ET
Size
5.2 KB